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Abstract The role of cellular phosphatase activity in regulation 
of smooth muscle L-type Ca 2+ channels was investigated using 
tautomycin, a potent and specific inhibitor of serin/threonin 
phosphatases type 1 and 2A. Tautomycin (1-100 nM) inhibited 
Ca 2÷ channel activity in smooth muscle cells isolated from human 
umbilical vein. Tautomycin-induced inhibition of Ca 2÷ channel 
activity was due to a reduction of channel availability which 
originated mainly from prolongation of the lifetime of unavailable 
states of the channel. Pretreatment of smooth muscle cells with 
the protein kinase inhibitor H-7 (10 ttM) prevented the inhibitory 
effect of tautomycin. Our results suggest modulation of slow 
gating between available and unavailable states as a mechanism 
of phosphorylation-dependent down-regulation of Ca 2÷ channels 
in vascular smooth muscle. 
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closed states. An increase in availability as well as in open 
probability of available channels was found as the basis of 
phosphorylation-dependent up-regulation of cardiac channels 
[3,8]. The changes in gating behavior associated with modula- 
tory phosphorylation of smooth muscle L-type Ca 2+ channels 
have not yet been clearly identified. 
The present study was aimed at characterization of changes 
in the gating behavior of single Ca 2+ channels induced by inhi- 
bition of basal dephosphorylation i  vascular smooth muscle 
cells. Our results suggest basal activity of protein phosphatases 
as a major determinant of kinetic properties of L-type channels 
in vascular smooth muscle. We provide evidence for inhibitory 
modulation of slow gating between available and unavailable 
states as the basis of phosphorylation-dependent down-regula- 
tion of smooth muscle Ca 2÷ channels. 
2. Materials and methods 
1. Introduction 
Basal activity of protein phosphatases has been suggested to 
control the function of L-type Ca 2+ channels by determining the 
lifetime of phosphorylated states of channel proteins or associ- 
ated regulatory proteins [1,2,3]. Recent evidence suggests phos- 
phorylation-dependent control of specific kinetic functions of 
cardiac L-type channels [2,3]. Modulatory phosphorylation of 
smooth muscle L-type channels differs strikingly from those of 
cardiac and skeletal muscle L-type channels, in that phospho- 
rylation appears to mediate not only stimulation but also inhi- 
bition of Ca 2+ channels in smooth muscle [4-7]. Phosphoryla- 
tion-dependent inhibition of smooth muscle L-type Ca 2÷ chan- 
nels has been demonstrated in studies with protein kinase acti- 
vators [6,7] as well as protein phosphatase inhibitors [4,5]. In- 
hibitory modulation of smooth muscle Ca 2+ channels may be 
based on (i) a reduction of channel availability, (ii) a reduction 
of open probability of available channels or (iii) suppression of 
both availability and open probability. For cardiac Ca 2+ chan- 
nels, phosphorylation/dephosphorylation has been suggested 
to affect both the slow gating between available and unavailable 
states of the channel as well as the fast gating between open and 
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Abbreviations." EGTA, ethylene glycol bis (fl-aminoethyl ether) 
N,N,N',N'-tetraacetic acid; H-7, 1-(5-isoquinolinylsulfonyl)-2-meth- 
ylpiperazine; HEPES, N-2-hydroxyethylpiperazine-N'-ethansulfonic 
acid; P0, a channel's probability of being in the open state; NP0, mean 
number of open channels given by the product of N (number of active 
channels in a patch) times P0. 
2.1. Cell preparation 
The media of human umbilical veins was enzymatically disaggre- 
gated to obtain single smooth muscle cells as described previously [9]. 
The cells were resuspended and stored in a high K ÷ low C1- extracellular 
solution (see below) at 4°C, and used for experimentation within 36 h. 
2.2. Current measurements 
Ba 2+ currents through single Ca 2÷ channels were recorded in the 
membrane of intact smooth muscle cells (cell-attached mode). Cell 
potential was set to approximately zero by use of a high K + low C1- 
extracellular solution [10] which contained (mM): 110 K + aspartate, 20 
KCI, 2 MgC12, 20 HEPES, 2 EGTA, pH was adjusted to 7.4 with 
N-methyl-D-glucamine, and pCa was adjusted according Robertson 
and Potter [11]. The pipette solution contained (mM): 10 BaCI2, 100 
NaC1, 30 TEA-CI and 15 HEPES, pH adjusted to 7.4. Patch pipettes 
were fabricated from borosilicate glass (Clark Electromedical Instru- 
ments; Pangbourne UK), and had resistances of 5-10 Mr2. All experi- 
ments were performed at room temperature. Part of the experiments 
were performed in presence of the dihydropyridine-Ca 2+ channel activa- 
tor S(-)-BayK 8644 (0.5/2M) which was added to the pipette solution. 
Other drugs were applied via a perfusion system which allowed com- 
plete exchange of the bath solution within approximately 15 s. 
Voltage clamp and current amplification was performed with a List 
EPC/7 patch-clamp amplifier (List, Darmstadt, Germany). For data 
analysis, current records were filtered at 1 kHz (-3 dB) and digitized 
at a rate of 5 kHz. For display, current records were filtered at 500 Hz 
(-3 dB) and digitized at a rate of 2 kHz. Voltage protocols were 
controlled with pClamp software (Axon Instruments, Foster City, CA, 
USA). Idealization of current records was performed with pClamp 
software, as well as with a custom made level detection software based 
on optimization of likelihood of transitions [12]. The availability of 
channels to open upon depolarization was expressed as the proportion 
of sweeps which showed at least one opening according to the applied 
criteria of level detection (Student's t-test) [12]. Stability of gating be- 
havior was tested in control experiments which demonstrated stability 
of open time distributions, unitary current amplitude and mean number 
of open channels in cell-attached patches of four cells in the absence of 
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pharmacological interventions over a period of 20 min. Averaged ata 
are given as mean + S.E.M. from the indicated number of experiments. 
Statistical nalysis was performed using Student's t-test for paired val- 
ues and differences were considered statistically significant at P < 0.05. 
2.3. Materials 
Collagenase, type CLS II and soybean trypsin inhibitor type were 
obtained from Worthington Biochemical Corporation (Freehold, NJ, 
USA); dispase type II was from Boehringer (Mannheim, Germany); 
fatty acid-free bovine serum albumin from Behring (Marburg, Ger- 
many); Hanks balanced salt solution was from Sera Lab Ltd. (Sussex, 
GB); S(-)-BayK 8644 and H-7 was from Research Biochemicals Incor- 
porated (Natic, MA, USA); tautomycin was purchased from Calbio- 
chem (San Diego, CA, USA), and all other chemicals from Sigma 
Chemical Co. (Deisenhofen, Germany). 
3. Results 
3.1. Tautomycin inhibits L-type Ca g+ channels in human 
vascular smooth muscle 
L-type channels were recorded in the cell-attached configura- 
tion using 10 mM Ba 2÷ as charge carrier. Under these condi- 
tions, channels exhibited a unitary conductance of approxi- 
mately 13 pS (12.9 + 2, n = 5) and a threshold of activation 
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Fig. 1. Inhibition of L-Type Ca 2+ channels by tautomycin. (A) Diary 
of channel activity (given as NP0) calculated from individual depolariz- 
ing voltage pulses (holding potential -70 mV, test potential -20 mV, 
duration 500 ms, rate 0.66 Hz). Exposure of the cell to 10 nM and 100 
nM tautomycin s indicated. (B) Individual current responses. Records 
are filtered at 500 Hz and digitized at 2 kHz. Zero current levels are 
indicated by arrows or dashed lines, respectively. (C)Ensemble average 
currents obtained from 200 depolarizations i  the absence (control) and 
in the presence of100 nM tautomycin. BayK 8644 (0.5,uM) was present 
in the pipette solution. 
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Fig. 2. Concentration-dependent inhibition of L-type Ca 2÷ channels by 
tautomycin and prevention ofits inhibitory action by H-7. Mean values 
of NP0 (% of control) + S.E.M. were calculated from the indicated 
number of experiments. Statistically significant differences (P < 0.05 
versus control) are indicated (*). BayK 8644 (0.5/.tM) was present in 
the pipette solution. 
substantially inhibited Ca 2+ channel activity at concentrations 
as low as 10 nM. Fig. 1 illustrates inhibitory effects induced by 
10 nM and 100 nM tautomycin on channel activity recorded 
in the presence of 0.5/.tM BayK 8644. Fig. 1A shows a diary 
plot of channel activity given as mean number of open channels 
(NP0) during individual depolarizing voltage steps from a hold- 
ing potential of -70 mV to a test potential of -20 mV. Mean 
NP0 (calculated for 5-10 min intervals) was clearly reduced 
from 0.2 to 0.12 and further down to 0.05 in the presence of 
10 nM and 100 nM tautomycin, respectively. At 100 nM tauto- 
mycin, a striking change in the activity pattern was observed. 
Extremely long periods without channel activity alternated with 
active periods in which NP0 of individual sweeps was almost as 
high as in control. Fig. 1B shows representative current races 
recorded in the absence and presence of 100 nM tautomycin. 
Corresponding ensemble average currents derived from 200 
depolarizing voltage steps are depicted in Fig. 1C. Single chan- 
nel amplitude remained unchanged in the presence of tautomy- 
cin, and open time distribution was only moderately affected. 
In most cells, tautomycin duced the occurrence of a relatively 
small proportion of extremely long-lasting channel openings. 
This effect varied considerably regarding the apparent time 
constant and proportion of the tautomycin-induced long-last- 
ing openings, and was not further analyzed in detail. The prom- 
inent effect of tautomycin was apparently an increase in the 
proportion of blank sweeps which resulted in a clear reduction 
of the current average (Fig. 1C). 
Fig. 2 shows the concentration-response relationship of the 
inhibitory action of tautomycin. The threshold of its inhibitory 
action was as low as 1 nM. At 100 nM tautomycin, NP0 was 
inhibited own to 36 + 8% (n = 4) of control. To test whether 
the tautomycin-induced inhibition of Ca 2+ channels is indeed 
due to inhibition of basal dephosphorylation, we performed a 
set of experiments in which the inhibitory effect of 100 nM 
tautomycin was tested in the presence of 10 pM H-7, a non 
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Fig. 3. Tautomycin-induced reduction of the proportion of active 
sweeps. The fraction of active sweeps was calculated for periods of 3 5 
min in the absence and presence of 100 nM tautomycin and shown for 
individual experiments. Filled symbols represent experiments inwhich 
BayK 8644 (0.5 pM) was present in the pipette solution. 
specific inhibitor of protein kinases. Based on the concept of 
reversible phosphorylation/dephosphorylation, stabilization of 
phosphorylated states of the channel or regulatory proteins by 
phosphatase inhibitors are expected to depend on the rate of 
basal phosphorylation. Thus, inhibition of protein kinases is 
expected to suppress the effects of phosphatase inhibition. Pre- 
incubation of cells with 10/.tM H-7 indeed completely antago- 
nized the effects of 100 nM tautomycin. No change in NP0 was 
induced by 100 nM tautomycin i  the presence of H-7 (n = 4) 
as illustrated in Fig. 2. 
3.2. Tautomycin-induced inhibition of smooth muscle Ca 2+ 
channels is due to prolongation of the lifetime of unavailable 
states of the channel 
Tautomycin (100 riM) consistently diminished the fraction of 
depolarizing pulses which elicited channel openings (active 
sweeps), indicating an inhibitory effect on channel availability. 
This result is illustrated in Fig. 3. To test whether modulation 
of channels by BayK 8644 is of relevance regarding the ob- 
served tautomycin effects on gating kinetics, the dihydropyrid- 
ine activator was omitted in a set of experiments. The results 
obtained with four patches which exhibited a sufficiently high 
channel activity for evaluation of inhibitory effects are included 
in Fig. 3. Irrespective of the presence or absence of the dihy- 
dropyridine activator, tautomycin reduced the proportion of 
active sweeps in each individual experiment. In one of the 
experiments performed in the absence of BayK 8644, only one 
single Ca 2+ channel was detected, and its activity could be 
recorded for more than 40 min. This situation allowed for a 
detailed analysis of the slow gating behavior. The channel was 
found available in about 50% of the depolarizing pulses. Fig. 
4A shows a diary-plot of the channel's P0- According to the idea 
of slow gating of Ca 2+ channels between available and unavail- 
able states [3,8], the occurrence of active and blank sweeps was 
clustered. Consecutive current records obtained in the absence 
and presence of tautomycin are illustrated in Fig. 4B. Tautomy- 
cin (100 nM) enhanced the proportion of blank sweeps (marked 
with B in Fig. 4B), while open probability of the channel during 
active sweeps remained almost unchanged. Tautomycin-in- 
duced suppression of channel availability was clearly borne out 
by a prolongation of uninterrupted clusters of blank sweeps 
(blank runs). Distribution of the lifetime of active and blank 
runs are shown in Fig. 3C. Data were best fitted with double 
exponential functions. Tautomycin exerted a modest effect on 
the duration of active runs but markedly increased the mean 
lifetime of blank runs (given as number of depolarizing pulses, 
i.e. sweeps). Time constants derived from active sweep histo- 
grams decreased from 0.8 and 4.9 (number of sweeps) in control 
to 0.3 and 2.8 in the presence of tautomycin, while time con- 
stants derived from blank sweep histograms increased from 
control values of 0.4 and 2.7 to 3.3 and 19,1 in the presence of 
tautomycin. Fast gating of the channel was barely affected by 
tautomycin as evident from analysis of open probability and 
open time distribution. Open probability of the available chan- 
nel was 0.14 in the absence and 0.11 in the presence of tautomy- 
cin. Biexponential fit of open time distributions yielded time 
constants of 0.4 ms for short and 5.9 ms for long openings in 
control, and 0.6 ms and 7.3 ms in the presence of tautomycin. 
The proportion of long lasting openings was 39% in control and 
42% in the presence of tautomycin. 
4. Discussion 
With the present study, we provide evidence for phosphoryl- 
ation-dependent i hibition of smooth muscle L-type Ca 2+ chan- 
nel activity, based on modulation of slow gating properties of 
the channel. Inhibition of basal dephosphorylation clearly pro- 
moted unavailable states of the Ca 2+ channel. Our results ug- 
gest that the slow gating between available and unavailable 
states of the channel is in large part determined by the activity 
of protein phosphatases in the smooth muscle cell. 
We used tautomycin to suppress basal dephosphorylation in 
human vascular smooth muscle cells. Tautomycin is a bacterial 
toxin which is known as a highly specific inhibitor of serine/ 
threonine phosphoprotein phosphatases [13]. Tautomycin 
markedly inhibited mean Ca 2÷ channel activity in human vascu- 
lar smooth muscle. This finding is in accordance with the con- 
cept of smooth muscle L-type Ca 2+ channels being subject o 
phosphorylation-dependent own-regulation [4-7]. Inhibitory 
phoshorylation of smooth muscle Ca 2+ channels has been sug- 
gested to involve cyclic nucleotide-dependent protein kinases 
[6] and/or specific isoforms of protein kinase C [7]. These mech- 
anisms of cellular egulation are considered as reversible phos- 
phorylation/dephosphorylation pr cesses. Thus inhibition of 
protein phosphatases may well promote low activity of smooth 
muscle Ca 2÷ channels. Our results are in line with previous 
reports demonstrating inhibition of whole-cell Ca 2÷ currents in 
smooth muscle by phosphatase inhibitors [4,5]. Tautomycin- 
induced inhibition of Ca 2+ channel activity was due to a reduc- 
tion of the channels' ability to open upon depolarization, i.e. 
the channels' availability. We have recently reported on a dual 
regulation of human smooth muscle Ca 2+ channels by activa- 
tion of protein kinase C [7], and demonstrated that protein 
kinase C-mediated inhibition is associated with reduced chan- 
nel availability. Similarly the inhibitory effect of tautomycin 
was found to be based predominantly on a reduction of channel 
K. Groschner et al./FEBS Letters 373 (1995) 30-34 33 
A 1+100 nM TAUTOMYCIN 
Po 
0,2 
o,o • I . 1,, J. rll 
0 10 2'0 " 30 rain 
R CONTROL 
' - "  -2o mV 
-7o mv_l L 
B ~ ~ ; = ~ ' - ~  
+TAUTOMYCIN 
_J L 
B i ~ ~,~-  ~ '~*~*- -~ 
B ~ ~  






















• .Q 25 25 
c 
o 2's 




duration (number of sweeps) 
Fig. 4. Tautomycin-induced hanges in slow gating behavior of a single Ca 2+ channel. (A) Diary of a channel's P0 calculated from individual 
depolarizing voltage pulses (holding potential -70 mV, test potential -20 mV, duration 500 ms, rate 0.66 Hz). (B) Consecutive current traces recorded 
in the absence and presence of 100 nM tautomycin. Closed state is indicated by arrows or dashed lines, respectively. Blank sweeps (B) are marked. 
Records are filtered at 500 Hz and digitized at 2 kHz. (C) Sweep histograms, plotting the number of runs (uninterrupted clusters of active or blank 
sweeps) against the duration of runs (number of sweeps) are shown for control and the presence of 100 nM tautomycin. No BayK 8644 was present 
in the pipette solution. 
availability. Thus, besides cyclic nucleotide-dependent pro ein 
kinases, isoforms of protein kinase C may be involved in the 
observed own-regulation f smooth muscle Ca 2+ channels. 
Considering the concept of reversible phosphorylation/ 
dephosphorylation as the basis of channel regulation, the effect 
of a phosphatase inhibitor should critically depend on the level 
of basal protein kinase activity. In accordance with this hypoth- 
esis, H-7, an inhibitor of protein kinase C and cyclic nucleotide- 
dependent protein kinases, prevented the effects of tautomycin. 
Analysis of slow gating of a single Ca 2+ channel in the ab- 
sence of BayK 8644 yielded blank sweep histograms which were 
best described by the sum of two exponential functions indicat- 
ing the existence of at least wo unavailable states of the chan- 
nel. A similar esult has been reported for cardiac hannels [3]. 
The phosphatase inhibitor tautomycin markedly prolonged the 
lifetime of unavailable states of the channel. This result suggests 
protein dephosphorylation as a mechanism involved in the gat- 
ing transition from unavailable toavailable states. It is tempting 
to interpret he effects of tautomycin on channel kinetics in 
terms of distinct phosphorylated states of the Ca 2+ channel 
which are stabilized by inhibition of basal dephosphorylation. 
This idea is in line with the finding that serine/threonine protein 
phosphatases selectively dephosphorylate different sites on the 
~1 and fl subunit of the Ca 2+ channel [14]. Since coupling be- 
tween voltage sensing and pore opening in the ~1 subunit was 
found to be determined by its interaction with the fl subunit 
[15], not only the pore forming ~1 subunit but also thee subunit 
of the channel complex may well serve as a target of modula- 
tory phosphorylation. The involvement of phosphorylation 
sites on regulatory proteins beside the channel complex, how- 
ever, cannot be ruled out at present. Nonetheless, our results 
provide clear evidence for phosphorylation-dependent down- 
regulation of smooth muscle Ca 2+ channels via suppression of
channel availability. 
Our study is the first demonstration f smooth muscle Ca 2+ 
channel slow gating being controlled via basal phosphatase 
activity. This mechanism ay be of particular physiologic and 
pathophysiologic relevance, since changes in cellular phosphat- 
ase activity have been suggested as key events in hormonal 
control of smooth muscle functions [16]. The presented results 
34 K. Grosehner et al. IFEBS Letters 373 (1995) 30-34 
suggest basal deposphorylation as a major determinant of 
smooth muscle Ca 2+ channel kinetics and consequently of volt- 
age-dependent Ca2+ entry into smooth muscle cells. 
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